In addition, overexpression of FOXO1 or manipulation of T cell metabolism by targeting isocitrate dehydrogenase 2 (IDH2) has been shown to facilitate the generation of memory-like CAR-T cells and improve their anti-tumor activity in vivo (38–40). This evidence concerns the gene FOXO1 and neoplasm.